Physician profile
Dean Kane
NPI 1467429951
$3,663.14
in general payments reported to CMS, 2019-2025
22 companies · $224 in 2025
The $224 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,251 · 2020: $92.24 · 2021: $211 · 2022: $119 · 2023: $256 · 2024: $509 · 2025: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $990.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $990.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $2,069.59 | 2019 | |
| Galderma Laboratories, L.P. | $562.26 | 2019-2023 | Oracea, Aklief |
| Sun Pharmaceutical Industries INC. | $176.57 | 2023-2025 | Ilumya, Odomzo, Blu-U |
| Leo Pharma INC. | $120.89 | 2024-2025 | Adbry |
| Janssen Biotech, INC. | $114.46 | 2024-2025 | Tremfya |
| Abbvie INC. | $77.37 | 2023-2025 | |
| Lilly USA, LLC | $74.76 | 2023-2025 | Taltz, Olumiant |
| Ucb, INC. | $54.50 | 2024-2025 | Bimzelx |
| Revance Therapeutics, INC. | $54.21 | 2024 | Daxxify |
| Almirall LLC | $49.55 | 2023 | Klisyri |
| Dermavant Sciences, INC. | $43.46 | 2023 | Vtama |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $38.09 | 2023-2024 | Arazlo |
| Lumenis, INC | $33.03 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $30.10 | 2024 | Dupixent |
| Incyte Corporation | $26.88 | 2024 | Opzelura |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $23.40 | 2024 | Zoryve |
| Novartis Pharmaceuticals Corporation | $23.12 | 2024 | |
| Mayne Pharma Commercial LLC | $22.25 | 2023 | |
| Mentor Worldwide LLC | $19.95 | 2021 | |
| Lnhc, INC | $18.92 | 2025 | Zelsuvmi |
| E.R. Squibb & Sons, L.L.C. | $17.55 | 2024 | Sotyktu |
| Acelrx Pharmaceuticals, INC. | $12.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dean Kane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.